Research Center, Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy.
ACS Chem Biol. 2012 Aug 17;7(8):1420-8. doi: 10.1021/cb300221f. Epub 2012 Jun 7.
Clostridium difficile is emerging worldwide as a major cause of nosocomial infections. The negatively charged PSII polysaccharide has been found in different strains of C. difficile and, thereby, represents an important target molecule for a possible carbohydrate-based vaccine. In order to identify a synthetic fragment that after conjugation to a protein carrier could be able to induce anti-PSII antibodies, we exploited a combination of chemical synthesis with immunochemistry, confocal immunofluorescence microscopy, and solid state NMR. We demonstrate that the phosphate group is crucial in synthetic glycans to mimic the native PSII polysaccharide; both native PSII and a phosphorylated synthetic hexasaccharide repeating unit conjugated to CRM(197) elicit comparable immunogenic responses in mice. This finding can aid design and selection of carbohydrate antigens to be explored as vaccine candidates.
艰难梭菌正在全球范围内成为医院感染的主要原因。带负电荷的 PSII 多糖已在艰难梭菌的不同菌株中被发现,因此,它是一种潜在基于碳水化合物疫苗的重要靶标分子。为了鉴定一种经与蛋白质载体缀合后能够诱导抗 PSII 抗体的合成片段,我们利用化学合成与免疫化学、共聚焦免疫荧光显微镜和固态 NMR 的组合来实现。我们证明了磷酸基团在模拟天然 PSII 多糖的合成糖中是至关重要的;天然 PSII 和与 CRM(197)缀合的磷酸化合成六糖重复单元都能在小鼠中引起类似的免疫反应。这一发现可以帮助设计和选择作为候选疫苗的碳水化合物抗原。